Ranitidine and Nitrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Nitrol (nitroglycerin). Common drug interactions include fatigue among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Nitrol. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Nitrol?

Nitrol has active ingredients of nitroglycerin. eHealthMe is studying from 3,069 Nitrol users. Check the latest studies of Nitrol.



On Jul, 19, 2026

38 people who take Ranitidine and Nitrol together, and have interactions are studied.

Ranitidine and Nitrol drug interactions.

What are the common drug interactions of Ranitidine and Nitrol, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Gallbladder disorder
  3. Impaired gastric emptying
  4. Injury
  5. Insomnia (sleeplessness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Memory impairment
  8. Night sweats (sweating in night)
  9. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  10. Anaemia (lack of blood)

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Diarrhoea
  3. Constipation
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Depression
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Haematuria (presence of blood in urine)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the common drug interactions of Ranitidine and Nitrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arrhythmia (irregular heartbeat)

40-49:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Muscle contractions involuntary (uncontrolled muscle contraction)
  3. Partial seizures (seizures which affect only a part of the brain at onset)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Vomiting

50-59:

  1. Night sweats (sweating in night)
  2. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  3. Anaemia (lack of blood)
  4. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Therapeutic response decreased (less preventive response)
  7. Acute myocardial infarction (acute heart attack)
  8. Chronic kidney disease
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Hypercholesterolaemia (high levels of cholesterol in the blood)

60+:

  1. Diarrhoea
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Hypotension (abnormally low blood pressure)
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Abdominal pain upper
  6. Activated partial thromboplastin time prolonged
  7. Anaemia (lack of blood)
  8. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  9. Anxiety
  10. Arrhythmia (irregular heartbeat)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 3 people, 7.89%
  2. Neuralgia (pain in one or more nerves): 3 people, 7.89%
  3. Muscle Spasms (muscle contraction): 3 people, 7.89%
  4. High Blood Pressure: 3 people, 7.89%
  5. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.26%
  6. Diabetes: 2 people, 5.26%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.26%
  8. Abdominal Pain Upper: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Nitrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Nitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and nitroglycerin (the active ingredients of Ranitidine and Nitrol, respectively), and Ranitidine and Nitrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: